Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

Author： Imbach P.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.5, Iss.12, 2003-01, pp. : 795-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Immune Thrombocytopenic Purpura in Children: Current Concepts

By Shad Aziza T.  

Pediatric Drugs, Vol. 7, Iss. 5, 2005-01 ,pp. : 325-336

Adis International

Access to resources Recommend Favorite

Juvenile idiopathic arthritis: current and future treatment options

By Martini Giorgia   Zulian Francesco  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 387-399

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 3, 2010-07 ,pp. : 158-172

Bentham Science Publishers

Access to resources Recommend Favorite

Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal

By Boyers Dwayne  

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 483-495

Adis International

Access to resources Recommend Favorite

Immune thrombocytopenic purpura – current management practices

By Sandler S Gerald   Tutuncuoglu S Osman  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2515-2527

Informa Healthcare

Access to resources Recommend Favorite